Lincoln Pharmaceuticals Ltd.

NSE: LINCOLN | BSE: 531633

Turnaround Potential

Download real time

734.15 2.00 (0.27%)

New 52W High today

146.5K NSE+BSE Volume

NSE 22 May, 2026 3:31 PM (IST)

1,470.5

Market Cap

Above industry Median

-

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Lincoln Pharma is on 28 May 2026 for the purpose of Audited Results & Final Dividend See details

Lincoln Pharmaceuticals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LINCOLN, BSE:531633 Lincoln Pharmaceuticals Ltd.

Is Lincoln Pharmaceuticals Ltd. worth buying?

181 Votes:

Buy 88.4%

Sell 5.52%

Hold 6.08%